AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
RDVT Red Violet
- 38.640
- +0.050+0.13%
Close Mar 21 16:00 ET
- 38.640
- 0.0000.00%
Post 16:15 ET
538.59MMarket Cap77.28P/E (TTM)
39.000High37.890Low79.68KVolume38.880Open38.590Pre Close3.06MTurnover0.78%Turnover Ratio77.28P/E (Static)13.94MShares43.44052wk High6.22P/B395.03MFloat Cap16.42352wk Low--Dividend TTM10.22MShs Float43.440Historical High--Div YieldTTM2.88%Amplitude4.314Historical Low38.434Avg Price1Lot Size
Red Violet Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.98%23.96M | 59.16%6.69M | 25.19%7.25M | 61.18%5.72M | 181.19%4.31M | 20.96%15.07M | -3.56%4.2M | 84.07%5.79M | 40.48%3.55M | -37.00%1.53M |
| Net income from continuing operations | -48.24%7M | 180.65%863K | -86.24%1.72M | 89.99%2.64M | 149.16%1.78M | 2,096.27%13.53M | 30.70%-1.07M | 453.37%12.5M | 777.07%1.39M | 569.16%716K |
| Depreciation and amortization | 14.49%9.56M | 12.21%2.48M | 12.11%2.43M | 15.73%2.38M | 18.48%2.27M | 25.12%8.35M | 21.82%2.21M | 26.74%2.17M | 27.34%2.05M | 24.90%1.92M |
| Deferred tax | 120.59%2.02M | -106.51%-33K | 109.30%970K | 296.10%610K | 1,670.00%471K | -11,112.36%-9.8M | 529.66%507K | -104,420.00%-10.43M | 600.00%154K | -117.14%-30K |
| Other non cash items | -3.47%556K | 9.09%144K | -7.28%140K | -6.76%138K | -7.59%134K | 5.30%576K | -6.38%132K | 8.63%151K | 9.63%148K | 9.85%145K |
| Change In working capital | 61.77%-1.55M | 86.94%1.72M | 262.22%146K | 1.91%-1.59M | 44.18%-1.83M | -207.02%-4.07M | -61.34%919K | 96.06%-90K | -245.32%-1.62M | -246.14%-3.27M |
| -Change in receivables | 52.83%-1.27M | 175.05%379K | -59.52%-595K | 68.78%-246K | 21.14%-806K | -36.24%-2.69M | -158.72%-505K | 84.13%-373K | -307.37%-788K | -18.56%-1.02M |
| -Change in prepaid assets | -50.29%-514K | 58.46%103K | -268.03%-247K | 153.33%8K | 29.87%-378K | -98.84%-342K | -16.67%65K | 41.35%147K | -111.72%-15K | -11.83%-539K |
| -Change in payables and accrued expense | 387.55%1.43M | 17.37%1.43M | 273.26%1.02M | 39.56%-388K | 53.50%-625K | -124.01%-498K | -37.18%1.22M | 36.50%273K | 12.65%-642K | -299.11%-1.34M |
| -Change in other current assets | -880.95%-656K | -269.09%-186K | 5.80%146K | -698.45%-772K | 153.24%156K | 118.10%84K | 123.71%110K | --138K | --129K | ---293K |
| -Change in other current liabilities | 11.08%-570K | -17.05%-151K | 17.14%-145K | 18.71%-139K | 18.67%-135K | -3.72%-641K | 20.37%-129K | -12.18%-175K | -12.50%-171K | -12.16%-166K |
| -Change in other working capital | 10.00%22K | -9.82%147K | 68.00%-32K | 59.56%-55K | -140.86%-38K | 111.70%20K | 24.43%163K | -20.48%-100K | -49.45%-136K | 172.66%93K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.98%23.96M | 59.16%6.69M | 25.19%7.25M | 61.18%5.72M | 181.19%4.31M | 20.96%15.07M | -3.56%4.2M | 84.07%5.79M | 40.48%3.55M | -37.00%1.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4.60%-9.57M | -7.99%-2.3M | 1.79%-2.42M | -9.81%-2.46M | -3.24%-2.39M | -3.59%-9.15M | 12.07%-2.13M | -7.10%-2.46M | -1.63%-2.24M | -21.50%-2.32M |
| Capital expenditure reported | -4.14%-9.4M | -8.42%-2.28M | 1.33%-2.38M | -7.83%-2.41M | -2.38%-2.33M | -6.72%-9.02M | 9.24%-2.1M | -7.39%-2.41M | -6.53%-2.24M | -26.70%-2.27M |
| Net PPE purchase and sale | -38.52%-169K | 29.17%-17K | 25.53%-35K | -642.86%-52K | -47.73%-65K | 67.29%-122K | 76.47%-24K | 6.00%-47K | 93.52%-7K | 61.06%-44K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4.60%-9.57M | -7.99%-2.3M | 1.79%-2.42M | -9.81%-2.46M | -3.24%-2.39M | -3.59%-9.15M | 12.07%-2.13M | -7.10%-2.46M | -1.63%-2.24M | -21.50%-2.32M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -73.96%-9.92M | 14.52%-3.64M | 94.26%-28K | -491.25%-4.46M | -772.82%-1.8M | 6.17%-5.7M | -203.28%-4.26M | 74.37%-488K | 72.73%-754K | -3,333.33%-206K |
| Net common stock issuance | -57.72%-5.85M | --0 | --0 | -503.81%-4.44M | -708.57%-1.42M | -322.67%-3.71M | -379.53%-2.46M | 6.58%-341K | ---735K | ---175K |
| Net other financing activities | -104.22%-4.07M | -102.62%-3.64M | 80.95%-28K | -5.26%-20K | -1,135.48%-383K | 61.69%-1.99M | -101.69%-1.8M | 90.45%-147K | 99.31%-19K | -416.67%-31K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -73.96%-9.92M | 14.52%-3.64M | 94.26%-28K | -491.25%-4.46M | -772.82%-1.8M | 6.17%-5.7M | -203.28%-4.26M | 74.37%-488K | 72.73%-754K | -3,333.33%-206K |
| Net cash flow | ||||||||||
| Beginning cash position | 0.70%32.03M | 4.49%35.75M | -1.35%30.94M | 4.31%32.15M | 0.70%32.03M | -7.15%31.81M | 9.39%34.21M | -2.97%31.37M | -11.38%30.82M | -7.15%31.81M |
| Current changes in cash | 1,914.41%4.47M | 134.76%757K | 69.04%4.8M | -318.91%-1.2M | 111.59%115K | 109.07%222K | -505.59%-2.18M | 369.38%2.84M | 122.48%550K | -291.88%-992K |
| End cash Position | 13.96%36.5M | 13.96%36.5M | 4.49%35.75M | -1.35%30.94M | 4.31%32.15M | 0.70%32.03M | 0.70%32.03M | 9.39%34.21M | -2.97%31.37M | -11.38%30.82M |
| Free cash flow | 142.92%14.39M | 111.56%4.39M | 45.11%4.83M | 149.54%3.25M | 343.38%1.91M | 63.22%5.93M | 7.06%2.08M | 292.23%3.33M | 310.06%1.3M | -250.29%-786K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |